Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Agenerase (Amprenavir) Capsules
Company:  GlaxoSmithKline
Application No.:  21-007/S006 & 21-039/S009
Approval Date: 5/11/2001


Date created: April 04, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.